These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 2498532)

  • 1. Intravesical mitomycin C instillation as a prophylactic treatment of superficial bladder tumor.
    Kim HH; Lee C
    J Urol; 1989 Jun; 141(6):1337-9; discussion 1339-40. PubMed ID: 2498532
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Intravesical mitomycin for superficial tumors of the bladder: difficulties of cystoscopic monitoring].
    Fourcade RO; Giuliano F
    Ann Urol (Paris); 1988; 22(6):404-6. PubMed ID: 3146942
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A trial of prophylactic thiotepa or mitomycin C intravesical therapy in patients with recurrent or multiple superficial bladder cancers.
    Flanigan RC; Ellison MF; Butler KM; Gomella LG; McRoberts JW
    J Urol; 1986 Jul; 136(1):35-7. PubMed ID: 3086575
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intravesical instillation of mitomycin-C in 242 patients with superficial bladder cancer at high risk of recurrence: long-term results.
    Hurle R; Manzetti A; Losa A; Micheli E; Ranieri A; Chinaglia D; Lembo A
    Urol Int; 1998; 61(4):220-6. PubMed ID: 10364753
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prophylactic intravesical instillation therapy with adriamycin and mitomycin C in patients with superficial bladder cancer.
    Tsushima T; Matsumura Y; Ozaki Y; Yoshimoto J; Ohmori H
    Cancer Chemother Pharmacol; 1987; 20 Suppl():S72-6. PubMed ID: 3117400
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recurrence of superficial bladder carcinoma after intravesical instillation of mitomycin-C. Comparison of exposure times.
    Giesbers AA; Van Helsdingen PJ; Kramer AE
    Br J Urol; 1989 Feb; 63(2):176-9. PubMed ID: 2495144
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Instillation of mitomycin C and doxorubicin in the prevention of recurrent superficial (Ta-T1) bladder cancer.
    Jauhiainen K; Alfthan O
    Br J Urol; 1987 Jul; 60(1):54-9. PubMed ID: 3113524
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Study of intravesical mitomycin C in patients with multiple prior occurrences of superficial bladder cancer.
    Schwarzman MI; Johanson KE; Surya B; Brown J
    Urology; 1988 Oct; 32(4):335-8. PubMed ID: 3140465
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of intravesical mitomycin C in the treatment of superficial transitional cell carcinoma of the urinary bladder.
    Pavlotsky A; Eidelman A; Barak F; Alon H; Horn Y
    J Surg Oncol; 1989 May; 41(1):9-11. PubMed ID: 2497274
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intravesical mitomycin C for the treatment of recurrent superficial bladder tumours.
    Hetherington JW; Newling DW; Robinson MR; Smith PH; Adib RS; Whelan P
    Br J Urol; 1987 Mar; 59(3):239-41. PubMed ID: 3105631
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of intravesical mitomycin C on recurrence of newly diagnosed superficial bladder cancer: interim report from the Medical Research Council Subgroup on Superficial Bladder Cancer (Urological Cancer Working Party).
    Tolley DA; Hargreave TB; Smith PH; Williams JL; Grigor KM; Parmar MK; Freedman LS; Uscinska BM
    Br Med J (Clin Res Ed); 1988 Jun; 296(6639):1759-61. PubMed ID: 3136828
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Postoperative prophylactic intravesical instillation of cytosine arabinoside and mitomycin C in superficial bladder tumor. A follow-up study.
    Omoto T; Kano M; Ariyoshi A; Momose S; Masaki Z; Morita I; Ishisawa N
    Urology; 1982 Nov; 20(5):510-4. PubMed ID: 6815854
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term observation after intravesical metaphylaxis with mitomycin C in patients with superficial bladder tumors.
    Maier U; Höbarth K
    Urology; 1991 May; 37(5):481-2. PubMed ID: 1902606
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytostatic intravesical instillation in patients with superficial bladder carcinoma for the prevention of recurrent tumors.
    Huland H; Klöppel G; Otto U; Feddersen I; Brachmann W; Hubmann H; Kaufmann J; Knipper W; Lantzius-Beninga F
    Eur Urol; 1988; 14(3):202-6. PubMed ID: 3133216
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term outcome of patients with frequently recurrent non-muscle-invasive bladder carcinoma treated with one perioperative plus four weekly instillations of mitomycin C followed by monthly bacillus Calmette-Guérin (BCG) or alternating BCG and interferon-α2b instillations: prospective randomised FinnBladder-4 study.
    Järvinen R; Marttila T; Kaasinen E; Rintala E; Aaltomaa S; Kallio J; Liukkonen T; Puolakka VM; Seppänen M; Tuhkanen K; Vaarala M; Viitanen J; Boström PJ;
    Eur Urol; 2015 Oct; 68(4):611-7. PubMed ID: 25748117
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunotherapy in bladder cancer with keyhole-limpet hemocyanin: a randomized study.
    Jurincic CD; Engelmann U; Gasch J; Klippel KF
    J Urol; 1988 Apr; 139(4):723-6. PubMed ID: 3127600
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Short schedule intravesical mitomycin preceding transurethral resection for recurrent Ta-T1, G1-G2 bladder cancer.
    Maffezzini M; Simonato A; Lodolo C; Raber M; Carmignani G
    Tumori; 1995; 81(3):191-3. PubMed ID: 7571026
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment schedule of intravesical chemotherapy with mitomycin C in superficial bladder cancer: short-term courses or maintenance therapy.
    van der Meijden AP; DeBruyne FM
    Urology; 1988 Mar; 31(3 Suppl):26-9. PubMed ID: 3126592
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is there an optimal treatment scheme for adjuvant intravesical therapy? Preliminary analysis of an EORTC protocol comparing early and delayed instillation with and without maintenance of either adriamycin or mitomycin-C in patients with superficial transitional carcinoma of the bladder.
    Kurth KH; Bouffioux C; Sylvester R; de Pauw M
    Prog Clin Biol Res; 1988; 269():525-37. PubMed ID: 3134663
    [No Abstract]   [Full Text] [Related]  

  • 20. Comparison of different schedules of cytostatic intravesical instillations in patients with superficial bladder carcinoma: final evaluation of a prospective multicenter study with 419 patients.
    Huland H; Klöppel G; Feddersen I; Otto U; Brachmann W; Hubmann H; Kaufmann J; Knipper W; Lantzius-Beninga F; Huland E
    J Urol; 1990 Jul; 144(1):68-71; discussion 71-2. PubMed ID: 2113590
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.